Background: Sexual dysfunction (SD) among male psychiatric patients is common and may be the result of various bio- psycho-social factors. This study aimed to assess the proportion of men with depression and/or anxiety disorders having SD and evaluate its association with sociodemographic and clinical variables. Methods: This cross-sectional study conducted from November 2018 to June 2020 included 100 men attending the psychiatry outpatient department of a tertiary care hospital. Sociodemographic and clinical variables, including diagnosis based on International Classification of Diseases 10th Revision criteria, were assessed. Sexual functioning was measured by the Change in Sexual Functioning Questionnaire-Male Version (CSFQ-M). Results: In the study, sexual pleasure dysfunction, sexual desire dysfunction, sexual desire/interest dysfunction, sexual arousal/erection dysfunction, and sexual orgasmic dysfunction were 71%, 71%, 66%, 68%, and 73%, respectively. Pearson correlation between Hamilton Depression Rating Scale score and sexual desire/interest component of CSFQ-M was r = 0.209 ( P = .008). Correlation between Hamilton Anxiety Rating Scale score and sexual desire/frequency component was r = 0.095 ( P = .012), sexual desire/interest component yielded r = 0.114 ( P = .029) and sexual arousal/erection component yielded r = 0.134 ( P = .052). Conclusions: Certain areas of sexual functioning are impacted by depression and/or anxiety disorders symptoms. The hypothesis that those with depression and/or anxiety would have lesser overall sexual functioning is supported in some areas by the results. Clinicians should be vigilant of this association and should plan treatment to enhance compliance and outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.